XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.21.1

Stock Awards | 3 Months Ended
--- | ---
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock Awards |
1 0. | STOCK AWARDS
In accordance with the Company’s 2013 Incentive Plan, stock awards, including stock options and restricted stock, have been granted to certain employees and non-employee directors. Shares of common stock available for distribution to satisfy the grants may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner. Stock-based compensation expense related to stock awards totaled $0.1 million for both of the three-month periods ended March 31, 2021 and 2020. Stock Options Stock option awards have been granted with an exercise price equal to the market price of the Company’s common stock on the date of the grant and have vesting periods ranging from one to three years, with 10-year contractual terms. The Company recognizes the cost of services received in exchange for stock option awards based on the grant date fair value of the award, with compensation expense recognized on a straight-line basis over the award’s vesting period. The fair value of outstanding awards was determined using the Black-Scholes option pricing model based on the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock. The Company did not grant any stock option awards during the three months ended March 31, 2021.
|  | 2020 |
Risk-free interest rate |  |  | 1.24 | %
Expected term (in years) |  |  | 7.5 |
Expected stock price volatility |  |  | 28.9 | %
Dividend yield |  |  | 1.25 | %
Fair value of stock option |  |  | 3.34 |
The following table summarizes the Company’s stock option activity for the periods presented.
|  | Three Months Ended |
|  | March 31, 2021 |  |  | March 31, 2020 |
|  | Number of Shares |  |  | Average Exercise Price |  |  | Number of Shares |  |  | Average Exercise Price |
Options: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding, beginning of period |  |  | 421,000 |  |  | $ | 9.79 |  |  |  | 412,800 |  |  | $ | 9.72 |
Granted |  |  | — |  |  |  | — |  |  |  | 10,200 |  |  |  | 11.95 |
Exercised |  |  | — |  |  |  | — |  |  |  | 666 |  |  |  | 10.75 |
Expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |  |  |  | 334 |  |  |  | 10.75 |
Options outstanding, end of period |  |  | 421,000 |  |  | $ | 9.79 |  |  |  | 422,000 |  |  | $ | 9.77 |
Options exercisable, end of period |  |  | 396,095 |  |  | $ | 9.74 |  |  |  | 352,517 |  |  | $ | 9.58 |
The aggregate intrinsic value of stock options outstanding (calculated as the amount by which the market value of underlying stock exceeds the exercise price of the option) was approximately $0.3 million and zero as of March 31, 2021 and 2020, respectively. Restricted Stock During the three months ended March 31, 2021 and 2020, respectively, 37,930 shares and 24,160 shares of restricted stock were granted. The Company recognizes the cost of services received in exchange for restricted stock awards based on the grant date closing price of the stock, with compensation expense recognized on a straight-line basis over the award’s vesting period.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration